Numat Technologies A Material to Save the World? Metal-organic frameworks are compounds that are set to solve some tough challenges: producing water in the desert, removing greenhouse gases from the…
Read More
Poseida Therapeutics BCMA in the spotlight as ASH abstracts drop Updated results from promising CAR-T therapies are expected November 2, 2108
Bellicum Pharmaceuticals, Inc. Bellicum Announces Data Presentations on Lead Product Candidate Rivo-cel and Controllable CAR Program at the 60th American Society of Hematology Annual Meeting November 1, 2018
AngelMD AngelMD Portfolio Company Raydiant Oximetry Awarded FDA Breakthrough Device Status The accelerated path to approval through the breakthrough device program will enable better care to millions of mothers and…
Marker Therapeutics, Inc. TapImmune And Marker Therapeutics Announce Successful Closing Of Previously Announced Merger And Financing October 17, 2018
Poseida Therapeutics Poseida Provides Update on Phase 1 Study of P-BCMA-101 CAR-T Stem Cell Memory Product in Patients with Relapsed/Refractory Multiple Myeloma Efficacy and safety continue to be a major…
Poseida Therapeutics Poseida Awarded $3.99 Million CIRM Grant to Support Preclinical Development of P-PSMA-101, a T Stem Cell Memory CAR-T Therapy for Prostate Cancer July 20, 2018
Numat Technologies NuMat Technologies Closes $12.4M Funding Round to Accelerate Commercialization of Molecularly Engineered Products April 26, 2018
Poseida Therapeutics Poseida raises $30.5 million for cancer cell therapy April 4, 2018
NexImmune Celgene vet Barer lines up a $23M startup round for next-gen I/O tech out of Johns Hopkins January 2, 2018